Position in GRFS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,082,355
+$773,607 QoQ
Shares Held
435,361
+51.2% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#30
of 165 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $396,101,149 across 12 Drug Manufacturers - General names. GRFS ranks #8 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
100,000 | $119,943,010 | |
| 2 | AMGN |
Amgen Inc
|
281,000 | $101,755,720 | |
| 3 | ABBV |
AbbVie Inc.
|
402,440 | $101,270,001 | |
| 4 | NVO |
Novo Nordisk A S
|
730,000 | $34,996,200 | |
| 5 | BIIB |
Biogen Inc.
|
90,000 | $19,445,400 | |
| 6 | PFE |
Pfizer Inc
|
435,000 | $10,474,800 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
56,540 | $3,257,834 | |
| 8 | GRFS |
Grifols SA
This page
|
435,361 | $3,082,355 |
All Filings in GRFS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,082,355 | 435,361 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,308,748 | 287,874 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,153,464 | 337,269 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,323,552 | 333,690 | Shares | Defined | 2025-12-15 | |
| 2025-06-30 | $3,016,557 | 333,690 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $2,372,535 | 333,690 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $17,340,000 | 1,500,000 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||